SHREYA GOEL
Projects
Investigating Actinium-225 Radiochemistry: A Step Towards Next-Generation Radiotherapy
The U.S. Department of Energy (DoE) highlighted potential applications of Actinium-225 (225Ac) in treating prostate cancer in 2018, opening a new era of alpha emitter-based targeted therapy. Alpha particle emitter, 225Ac has high linear energy transf...
Collaborators
| SIXIANG SHI (Project Owner) | School of Medicine, Radiology Research |
| SHREYA GOEL | College of Pharmacy, Molecular Pharmaceutics |
| Tara Mastren | College of Engineering, Civil And Environmental Engg |
Status: Funded 2023